Curanex Pharmaceuticals Inc (CURX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Curanex Pharmaceuticals Inc (CURX) closed at USD 4.96 on 2026-10-14, a change of -67.4 % over the past year, with a market capitalization of USD 7.57M.

Curanex Pharmaceuticals Inc recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Curanex Pharmaceuticals Inc key figures

Previous close

USD 4.96 (2026-10-14)

1-year change

-67.4 %

Market cap

USD 7.57M

Enterprise value

USD 4.91M

P/E ratio (trailing)

-0.61

P/E ratio (forward)

n/a

EPS (trailing)

-7.96

EPS (forward)

n/a

PEG ratio

n/a

Price to book

1.43

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.13

Employees

6

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Curanex Pharmaceuticals Inc and compare it with other stocks.